Guardant360® CDx is the first companion diagnostic to be approved in Japan to identify ESR1 mutations in patients with hormone receptor-positive, HER2-negative breast cancer for treatment with imlunestrant TOKYO, Dec. 22, 2025 /PRNewswire/ -- Guardant Health Japan Corp. today announced that the Ministry of Health, Labour and Welfare (MHLW) has approved Guardant360® CDx on 23 October 2025 ...
Guardant360® CDx is the first companion diagnostic to be approved in Japan to identify ESR1 mutations in patients with hormone receptor-positive, HER2-negative breast cancer for treatment with imlunestrant TOKYO, Dec. 22, 2025 /PRNewswire/ -- Guardant Health Japan Corp. today announced that the Ministry of Health, Labour and Welfare (MHLW) has approved Guardant360® CDx on 23 October 2025 ...
SHENZHEN, China, Dec. 22, 2025 /PRNewswire/ -- In an increasingly digital era, modern life and economic activities heavily rely on networks. Network stability directly impacts public 'digital well-being' and 'sense of social participation.' As the brain of the network, the core network must remain stable, since any service interruption can affect tens of millions of users, causing immeasurable soc...
SHENZHEN, China, Dec. 22, 2025 /PRNewswire/ -- In an increasingly digital era, modern life and economic activities heavily rely on networks. Network stability directly impacts public 'digital well-being' and 'sense of social participation.' As the brain of the network, the core network must remain stable, since any service interruption can affect tens of millions of users, causing immeasurable soc...
SHANGHAI, Dec. 22, 2025 /PRNewswire/ -- Nan Yang Textile Group has been honoured at the International Innovation Awards (IIA) 2025, organized by Enterprise Asia, for the development of Elitech 360°, an advanced fabric technology designed to deliver optimal performance across a wide range of applications. Elitech 360° is a lightweight, high-performance fabric engineered with true...
SHANGHAI, Dec. 22, 2025 /PRNewswire/ -- Nan Yang Textile Group has been honoured at the International Innovation Awards (IIA) 2025, organized by Enterprise Asia, for the development of Elitech 360°, an advanced fabric technology designed to deliver optimal performance across a wide range of applications. Elitech 360° is a lightweight, high-performance fabric engineered with true...
SHANGHAI, Dec. 22, 2025 /PRNewswire/ -- OK Biotech Co., Ltd. has been honoured at the International Innovation Awards (IIA) 2025, organized by Enterprise Asia, for its development of the OKB OTC Hearing Aid, a device designed to improve comfort and sound clarity for adults with hearing loss. The OKB OTC Hearing Aid was created from personal experience, with the company's Chairman—who has lived w...
SHANGHAI, Dec. 22, 2025 /PRNewswire/ -- OK Biotech Co., Ltd. has been honoured at the International Innovation Awards (IIA) 2025, organized by Enterprise Asia, for its development of the OKB OTC Hearing Aid, a device designed to improve comfort and sound clarity for adults with hearing loss. The OKB OTC Hearing Aid was created from personal experience, with the company's Chairman—who has lived w...
HONG KONG, Dec. 22, 2025 /PRNewswire/ -- On December 19, 2025, Hong Kong hosted the forum "Problem-Solving City: Hong Kong as a Disputes Resolver", co-organized by Friday Culture Limited, Hong Kong Coalition, and the AALCO Hong Kong Regional Arbitration Centre. The event brought together senior government officials, legal experts, and industry leaders to position Hong Kong as a glob...
HONG KONG, Dec. 22, 2025 /PRNewswire/ -- On December 19, 2025, Hong Kong hosted the forum "Problem-Solving City: Hong Kong as a Disputes Resolver", co-organized by Friday Culture Limited, Hong Kong Coalition, and the AALCO Hong Kong Regional Arbitration Centre. The event brought together senior government officials, legal experts, and industry leaders to position Hong Kong as a glob...
Disclaimer: We are a tourism service provider that provides room booking services for Ally's home 1 We are not the official website of the hotel, please be aware.
